Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.47 +0.02 (+0.19%) As of 07/24/2025 10:07 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. ORC, FBRT, NXRT, PAX, NOAH, AC, GETY, AACT, PLYM, and TINVShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Orchid Island Capital (ORC), Franklin BSP Realty Trust (FBRT), NexPoint Residential Trust (NXRT), Patria Investments (PAX), Noah (NOAH), Associated Capital Group (AC), Getty Images (GETY), Ares Acquisition Corporation II (AACT), Plymouth Industrial REIT (PLYM), and Tiga Acquisition (TINV). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors Orchid Island Capital Franklin BSP Realty Trust NexPoint Residential Trust Patria Investments Noah Associated Capital Group Getty Images Ares Acquisition Corporation II Plymouth Industrial REIT Tiga Acquisition Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Orchid Island Capital (NYSE:ORC) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership. Do analysts rate OACC or ORC? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Orchid Island Capital 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer OACC or ORC? In the previous week, Orchid Island Capital had 5 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 6 mentions for Orchid Island Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Orchid Island Capital's score of 0.34 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Oaktree Acquisition Corp. III Life Sciences Very Positive Orchid Island Capital Neutral Which has stronger earnings and valuation, OACC or ORC? Orchid Island Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AOrchid Island Capital$52.24M17.67$37.66M$0.4018.21 Is OACC or ORC more profitable? Orchid Island Capital's return on equity of 1.52% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Orchid Island Capital N/A 1.52%0.17% Do institutionals & insiders have more ownership in OACC or ORC? 32.7% of Orchid Island Capital shares are owned by institutional investors. 0.4% of Orchid Island Capital shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryOrchid Island Capital beats Oaktree Acquisition Corp. III Life Sciences on 7 of the 8 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$234.74M$166.94M$6.42B$9.52BDividend YieldN/AN/A4.19%3.99%P/E RatioN/AN/A14.0720.01Price / SalesN/AN/A1,734.40102.39Price / CashN/A36,857.63128.7058.97Price / BookN/AN/A1.965.87Net IncomeN/A-$160K$1.24B$258.50M7 Day Performance0.38%0.45%0.39%1.95%1 Month Performance-0.19%0.93%3.62%12.31%1 Year PerformanceN/A6.02%23.68%19.02% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.47+0.2%N/AN/A$234.74MN/A0.00N/APositive NewsORCOrchid Island Capital3.1199 of 5 stars$7.06-0.3%N/A-11.7%$897.15M$241.58M17.652,018News CoverageEarnings ReportFBRTFranklin BSP Realty Trust3.9507 of 5 stars$10.47-2.2%$15.13+44.5%-23.0%$880.52M$210.45M15.40N/APositive NewsUpcoming EarningsNXRTNexPoint Residential Trust4.8637 of 5 stars$34.00-0.9%$43.58+28.2%-21.0%$867.28M$255.34M-26.563Upcoming EarningsPAXPatria Investments2.8045 of 5 stars$13.87-0.1%$14.00+0.9%+7.6%$841.09M$390.10M27.74390News CoverageHigh Trading VolumeNOAHNoah3.4742 of 5 stars$12.23+1.2%$12.00-1.9%+65.0%$799.97M$2.57B12.611,990Positive NewsACAssociated Capital Group2.2559 of 5 stars$37.52+0.0%N/A+13.0%$792.89M$12.29M20.9620GETYGetty Images2.6906 of 5 stars$1.73-0.9%$4.35+152.2%-47.6%$719.35M$939.29M-9.081,700AACTAres Acquisition Corporation IIN/A$11.38flatN/A+6.4%$703.96MN/A0.00N/APLYMPlymouth Industrial REIT3.802 of 5 stars$15.46+0.5%$21.10+36.5%-34.9%$700.98M$198.35M5.0740Positive NewsTINVTiga AcquisitionN/A$19.94-5.9%N/A+69.1%$687.93MN/A0.00N/AHigh Trading Volume Related Companies and Tools Related Companies Orchid Island Capital Competitors Franklin BSP Realty Trust Competitors NexPoint Residential Trust Competitors Patria Investments Competitors Noah Competitors Associated Capital Group Competitors Getty Images Competitors Ares Acquisition Corporation II Competitors Plymouth Industrial REIT Competitors Tiga Acquisition Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
